Why is Sumitomo Chemi. falling/rising?

Recent Price Movement and Market Context

Sumitomo Chemical India Ltd has been under pressure recently, with the stock falling 2.66% over the past week while the Sensex gained 0.79% in the same period. The decline is more pronounced over the last month, where the stock has dropped 14.52%, contrasting with a 0.95% rise in the benchmark index. Year-to-date, the stock is down 15.40%, whereas the Sensex has advanced by 9.08%. This underperformance extends to the one-year horizon, with the stock losing 11.68% compared to the Sensex’s 10.47% gain. Even over three and five years, Sumitomo Chemical’s returns lag behind the broader market, highlighting persistent challenges in delivering competitive growth.

On 21-Nov, the stock traded close to its 52-week low, just 1.3% above the bottom price of ₹446.70, signalling investor caution. Despite outperforming its sector by 0.39% on the day, the stock has been falling for two consecutive days, losing 1.24% in that short span. Technical indicators also point to weakness, with the share price trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – suggesting a bearish trend.

Investor participation appears to be waning, as evidenced by a sharp 58.08% drop in delivery volume on 20 Nov compared to the five-day average. Although liquidity remains adequate for moderate trade sizes, the reduced investor interest may be contributing to the stock’s downward momentum.

Fundamental Performance and Valuation Concerns

While Sumitomo Chemical India Ltd benefits from high management efficiency, reflected in a robust return on equity (ROE) of 18.58%, the company’s growth metrics raise concerns. Over the past five years, net sales have grown at a modest annual rate of 5.60%, and operating profit has increased by 9.35% annually. These figures suggest limited expansion relative to peers and market expectations.

Moreover, the company reported flat results in the September 2025 half-year, with a notably low debtors turnover ratio of 0.37 times, indicating potential inefficiencies in receivables management. Despite a strong ROE, the stock’s valuation appears stretched, trading at a price-to-book value of 7.1, which is significantly higher than its peers’ historical averages. This premium valuation is difficult to justify given the company’s subdued growth and operational challenges.

Investors have also been wary due to the stock’s negative returns over the past year (-11.68%) despite a 12.3% rise in profits, resulting in a high price/earnings to growth (PEG) ratio of 3.4. This suggests that the market perceives the stock as overvalued relative to its earnings growth potential. The stock’s underperformance relative to the BSE500 index over multiple time frames further underscores its struggles to deliver competitive returns.

Balance of Strengths and Weaknesses

Sumitomo Chemical India Ltd’s low debt-to-equity ratio, effectively zero, is a positive factor that reduces financial risk and provides flexibility. The majority ownership by promoters may also offer stability in governance. However, these positives have not been sufficient to offset concerns about the company’s growth trajectory and valuation premium.

In summary, the stock’s recent decline is driven by a combination of weak long-term growth, flat recent results, expensive valuation metrics, and technical weakness. While management efficiency remains high, the market appears cautious about the company’s ability to sustain earnings growth at current price levels. Investors may be seeking better value propositions elsewhere, contributing to the falling investor participation and downward price pressure.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →